Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01700400
Title Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors "Cancer Research and Biostatistics Clinical Trials Consortium|University of Arizona|Providence Cancer Center, Earle A. C
Indications

lung non-small cell carcinoma

Therapies

Carboplatin

Everolimus

Bevacizumab

Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.